BioHealth News

The Launchport: We Asked CHATGPT What Makes the Maryland Medtech Ecosystem Unique

The Launchport: We Asked CHATGPT What Makes the Maryland Medtech Ecosystem Unique

Read More
TEDCO Announces Entrepreneur Expo Keynote Speakers

TEDCO Announces Entrepreneur Expo Keynote Speakers

Read More
GEN: Top 50 NIH-Funded Institutions of 2024

GEN: Top 50 NIH-Funded Institutions of 2024

Read More
New NIH Research Awards Support Community-Led Research to Reduce Health Disparities

New NIH Research Awards Support Community-Led Research to Reduce Health Disparities

Read More
Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Read More
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

Read More
Children’s National, Additional Ventures announce finalists in pediatric medical device competition

Children’s National, Additional Ventures announce finalists in pediatric medical device competition

Read More
BioBridges’ Expands Services with Dedicated MedTech Division

BioBridges’ Expands Services with Dedicated MedTech Division

Read More
IPWatchdog LIVE 2024

IPWatchdog LIVE 2024

Read More
Gaithersburg’s Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Gaithersburg’s Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Read More
WBJ: Children’s National lands $35M gift to advance prenatal, neonatal treatment

WBJ: Children’s National lands $35M gift to advance prenatal, neonatal treatment

Read More
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Read More
miRecule Showcases Innovative RNA Therapies this week at RESI Boston 2024

miRecule Showcases Innovative RNA Therapies this week at RESI Boston 2024

Read More
NIH Awards Sonavex $2 Million Grant to Conduct Clinical Trial and Seek Regulatory Clearance of EchoGuide

NIH Awards Sonavex $2 Million Grant to Conduct Clinical Trial and Seek Regulatory Clearance of EchoGuide

Read More
Gaithersburg’s Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407

Gaithersburg’s Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407

Read More
View All Posts